{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:38:50Z","timestamp":1789850330957,"version":"4.0.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1,8]]},"DOI":"10.1097\/wnr.0000000000000012","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T13:04:08Z","timestamp":1382360648000},"page":"7-11","source":"Crossref","is-referenced-by-count":19,"title":["L-Stepholidine, a naturally occurring dopamine D1 receptor agonist and D2 receptor antagonist, attenuates heroin self-administration and cue-induced reinstatement in rats"],"prefix":"10.1097","volume":"25","author":[{"given":"Kai","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baomiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210201","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0896-6273(00)80557-7","article-title":"Neuroscience of addiction.","volume":"21","author":"Koob","year":"1998","journal-title":"Neuron"},{"key":"R3-2-20210201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.54.1.1","article-title":"Neurobiology of relapse to heroin and cocaine seeking: a review.","volume":"54","author":"Shalev","year":"2002","journal-title":"Pharmacol Rev"},{"key":"R4-2-20210201","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0091-3057(02)00749-9","article-title":"Comparison of the reinforcing efficacy of two dopamine D2-like receptor agonists in rhesus monkeys using a progressive-ratio schedule of reinforcement.","volume":"72","author":"Woolverton","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"R5-2-20210201","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/00952990802122564","article-title":"Pharmacogenetic treatments for drug addiction: alcohol and opiates.","volume":"34","author":"Haile","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R6-2-20210201","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0165-6147(94)90158-9","article-title":"Dopamine receptor agonists, partial agonists and psychostimulant addiction.","volume":"15","author":"Pulvirenti","year":"1994","journal-title":"Trends Pharmacol Sci"},{"key":"R7-2-20210201","first-page":"415","article-title":"Drug addiction. Part III. Pharmacotherapy of addiction.","volume":"53","author":"Vetulani","year":"2001","journal-title":"Pol J Pharmacol"},{"key":"R8-2-20210201","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neulet.2012.02.041","article-title":"SKF 38393 reverses cocaine-conditioned place preference in mice.","volume":"513","author":"Sabioni","year":"2012","journal-title":"Neurosci Lett"},{"key":"R9-2-20210201","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pbb.2010.08.002","article-title":"The dopamine D(2) partial agonist and antagonist terguride decreases heroin self-administration on fixed- and progressive-ratio schedules.","volume":"97","author":"Zhang","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"R13-2-20210201","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0091-3057(03)00089-3","article-title":"Suppression of morphine-induced conditioned place preference by L-12-chloroscoulerine, a novel dopamine receptor ligand.","volume":"75","author":"Liu","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"R15-2-20210201","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejphar.2008.11.031","article-title":"Levo-tetrahydropalmatine attenuates oxycodone-induced conditioned place preference in rats.","volume":"602","author":"Liu","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"R16-2-20210201","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/syn.20855","article-title":"L-Stepholidine-induced excitation of dopamine neurons in rat ventral tegmental area is associated with its 5-HT(1A) receptor partial agonistic activity.","volume":"65","author":"Gao","year":"2011","journal-title":"Synapse"},{"key":"R17-2-20210201","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jneumeth.2006.01.004","article-title":"SuperState: a computer program for the control of operant behavioral experimentation.","volume":"155","author":"Zhang","year":"2006","journal-title":"J Neurosci Methods"},{"key":"R18-2-20210201","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008877-199710000-00007","article-title":"The effects of D-amphetamine on the reinforcing effects of food and fluid using a novel procedure combining self-administration and location preference.","volume":"8","author":"Evans","year":"1997","journal-title":"Behav Pharmacol"},{"key":"R19-2-20210201","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.brainresrev.2008.08.002","article-title":"Neurobiological mechanisms of the reinstatement of drug-conditioned place preference.","volume":"59","author":"Aguilar","year":"2009","journal-title":"Brain Res Rev"},{"key":"R20-2-20210201","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.30","article-title":"Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens.","volume":"12","author":"Bardo","year":"1998","journal-title":"Crit Rev Neurobiol"},{"key":"R21-2-20210201","first-page":"177","article-title":"Animal models of substance abuse and addiction: implications for science, animal welfare, and society.","volume":"60","author":"Lynch","year":"2010","journal-title":"Comp Med"},{"key":"R22-2-20210201","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nature04172","article-title":"Morphine reward in dopamine-deficient mice.","volume":"438","author":"Hnasko","year":"2005","journal-title":"Nature"},{"key":"R23-2-20210201","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2005.09.025","article-title":"The role of dopamine in human addiction: from reward to motivated attention.","volume":"526","author":"Franken","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R24-2-20210201","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","article-title":"Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures.","volume":"14","author":"Mello","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"R25-2-20210201","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1073\/pnas.97.8.4321","article-title":"Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens.","volume":"97","author":"Weiss","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"R26-2-20210201","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1017\/S1461145709000054","article-title":"Dopamine D1 receptor antagonism in the prelimbic cortex blocks the reinstatement of heroin-seeking in an animal model of relapse.","volume":"12","author":"See","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"R27-2-20210201","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1017\/S1461145708008778","article-title":"A role for dopamine D1-like receptors in acute food deprivation-induced reinstatement of heroin seeking in rats.","volume":"12","author":"Tobin","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"R28-2-20210201","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.2174\/092986707782794050","article-title":"Recent developments in studies of L-stepholidine and its analogs: chemistry, pharmacology and clinical implications.","volume":"14","author":"Mo","year":"2007","journal-title":"Curr Med Chem"},{"key":"R29-2-20210201","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.neurobiolaging.2008.06.017","article-title":"L-Stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinsons disease.","volume":"31","author":"Mo","year":"2010","journal-title":"Neurobiol Aging"}],"container-title":["NeuroReport"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNR.0000000000000012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T08:08:12Z","timestamp":1620979692000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001756-201401080-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,8]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/wnr.0000000000000012","relation":{},"ISSN":["0959-4965"],"issn-type":[{"value":"0959-4965","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,8]]}}}